StockData
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW

Abpro Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41+0.00 (+0.11%)

Close on Oct 19, 2026

Market cap
$2.41M
P/E (TTM)
–
Dividend yield
–

Abpro statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison

Valuation

MeasureAbproIndustry median
Market Cap$2.41M$166.30M
Enterprise Value-$1.28M$87.12M

Income (trailing twelve months)

MeasureAbproIndustry median
Operating Income-$8.45M-$21.49M
EBITDA-$8.43M-$17.14M
EPS (Diluted)-$1.30-$0.83

Balance sheet

MeasureAbproIndustry median
Cash & Short-Term Investments$4.24M$62.64M
Net Cash (Debt)$4.24M$15.77M
Net Cash Per Share$0.72$0.66
Equity (Book Value)-$3.53M$48.61M
Book Value Per Share-$0.60$1.36
Tangible Book Value-$3.53M$23.01M
Working Capital-$3.15M$75.09M

Financial position

MeasureAbproIndustry median
Current Ratio0.623.30
Quick Ratio0.522.39
Interest Coverage-7.49-7.12

Cash flow (trailing twelve months)

MeasureAbproIndustry median
Operating Cash Flow-$6.01M-$12.39M

Efficiency

MeasureAbproIndustry median
Employee Count174

Dividends and yields

MeasureAbproIndustry median
Buyback Yield-5.49%-0.73%
Shareholder Yield-5.49%0.00%

Shares

MeasureAbproIndustry median
Shares Outstanding5,896,05058,139,000
Shares Change (YoY)186.1%11.1%
Shares Change (QoQ)0.00%0.54%
Shares Held by Institutions0.00%59.4%

Scores

MeasureAbproIndustry median
Altman Z-Score-38.18-0.27

Calculated by StockData from Abpro's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.